NM_000059.4(BRCA2):c.8470A>T (p.Arg2824Ter) AND Hereditary breast ovarian cancer syndrome
- Germline classification:
- Likely pathogenic (2 submissions)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000496945.11
Allele description [Variation Report for NM_000059.4(BRCA2):c.8470A>T (p.Arg2824Ter)]
NM_000059.4(BRCA2):c.8470A>T (p.Arg2824Ter)
Condition(s)
- Name:
- Hereditary breast ovarian cancer syndrome
- Synonyms:
- Hereditary breast and ovarian cancer syndrome; Hereditary breast and ovarian cancer; Hereditary breast and ovarian cancer syndrome (HBOC); See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0003582; MeSH: D061325; MedGen: C0677776; Orphanet: 145
-
Homo sapiens chromosome 1 open reading frame 43 (C1orf43), transcript variant 5,...
Homo sapiens chromosome 1 open reading frame 43 (C1orf43), transcript variant 5, mRNAgi|1677501821|ref|NM_001297718.2|Nucleotide
-
Review of clinical effectiveness - Clinical effectiveness and cost-effectiveness...
Review of clinical effectiveness - Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model
-
Results from the cost-effectiveness model - Clinical effectiveness and cost-effe...
Results from the cost-effectiveness model - Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 26, 2024